PrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up.
Lailler C, Didelot A, Garinet S, Berthou H, Sroussi M, de Reyniès A, Dedhar S, Martin-Lannerée S, Fabre E, Le Pimpec-Barthes F, Perrier A, Poindessous V, Mansuet-Lupo A, Djouadi F, Launay JM, Laurent-Puig P, Blons H, Mouillet-Richard S.
Lailler C, et al. Among authors: mansuet lupo a.
Oncogene. 2024 Sep;43(37):2781-2794. doi: 10.1038/s41388-024-03130-0. Epub 2024 Aug 15.
Oncogene. 2024.
PMID: 39147880
Free PMC article.